Overview

A Controlled Clinical Trial on The Use of a Specific Antivenom Against Envenoming by Bungarus Multicinctus

Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
In northern Vietnam, a vast majority of the most severe envenomed patients are bitten by Bungarus multicinctus. Hitherto, these victims have received supportive care only. The aims of this study were to assess the possible efficacy and side effects of a newly produced antivenom.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Hanoi Medical University
Collaborators:
Karolinska Institutet
Swedish International Development Cooperation Agency (SIDA)
Treatments:
Antivenins